These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8298790)
1. Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium. Medhurst AD; Kaumann AJ Br J Pharmacol; 1993 Nov; 110(3):1023-30. PubMed ID: 8298790 [TBL] [Abstract][Full Text] [Related]
2. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines. Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202 [TBL] [Abstract][Full Text] [Related]
4. L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Smriga M; Torii K Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15370-5. PubMed ID: 14676321 [TBL] [Abstract][Full Text] [Related]
12. Effects of hallucinogenic drugs on the human heart. Neumann J; Dhein S; Kirchhefer U; Hofmann B; Gergs U Front Pharmacol; 2024; 15():1334218. PubMed ID: 38370480 [TBL] [Abstract][Full Text] [Related]
13. Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease. Neumann J; Hofmann B; Dhein S; Gergs U Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902195 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of bufotenin on human 5-HT Neumann J; Schulz N; Fehse C; Azatsian K; Čináková A; Marušáková M; Hofmann B; Gergs U Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1471-1485. PubMed ID: 36754881 [TBL] [Abstract][Full Text] [Related]
15. Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium. Weninger S; De Maeyer JH; Lefebvre RA Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):565-77. PubMed ID: 22426996 [TBL] [Abstract][Full Text] [Related]
16. Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development. De Maeyer JH; Straetemans R; Schuurkes JA; Lefebvre RA Br J Pharmacol; 2006 Jan; 147(2):140-57. PubMed ID: 16331294 [TBL] [Abstract][Full Text] [Related]
17. Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants. Krobert KA; Brattelid T; Levy FO; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):473-9. PubMed ID: 16012870 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Pau D; Workman AJ; Kane KA; Rankin AC Br J Pharmacol; 2003 Dec; 140(8):1434-41. PubMed ID: 14623763 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists. Leung E; Pulido-Rios MT; Bonhaus DW; Pekins LA; Zeitung KD; Hsu SA; Clark RD; Wong EH; Eglen RM Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):145-56. PubMed ID: 8857591 [TBL] [Abstract][Full Text] [Related]
20. Blockade of human and porcine myocardial 5-HT4 receptors by SB 203186. Parker SG; Taylor EM; Hamburger SA; Vimal M; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):28-35. PubMed ID: 8750913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]